Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

10 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Azathioprine induction of tumors with microsatellite instability: risk evaluation using a mouse model.
Bodo S, Svrcek M, Sourrouille I, Cuillières-Dartigues P, Ledent T, Dumont S, Dinard L, Lafitte P, Capel C, Collura A, Buhard O, Wanherdrick K, Chalastanis A, Penard-Lacronique V, Fabiani B, Fléjou JF, Brousse N, Beaugerie L, Duval A, Muleris M. Bodo S, et al. Among authors: chalastanis a. Oncotarget. 2015 Sep 22;6(28):24969-77. doi: 10.18632/oncotarget.4638. Oncotarget. 2015. PMID: 26327213 Free PMC article.
Specific clinical and biological features characterize inflammatory bowel disease associated colorectal cancers showing microsatellite instability.
Svrcek M, El-Bchiri J, Chalastanis A, Capel E, Dumont S, Buhard O, Oliveira C, Seruca R, Bossard C, Mosnier JF, Berger F, Leteurtre E, Lavergne-Slove A, Chenard MP, Hamelin R, Cosnes J, Beaugerie L, Tiret E, Duval A, Fléjou JF. Svrcek M, et al. Among authors: chalastanis a. J Clin Oncol. 2007 Sep 20;25(27):4231-8. doi: 10.1200/JCO.2007.10.9744. J Clin Oncol. 2007. PMID: 17878476
Azathioprine-induced carcinogenesis in mice according to Msh2 genotype.
Chalastanis A, Penard-Lacronique V, Svrcek M, Defaweux V, Antoine N, Buhard O, Dumont S, Fabiani B, Renault I, Tubacher E, Fléjou JF, Te Riele H, Duval A, Muleris M. Chalastanis A, et al. J Natl Cancer Inst. 2010 Nov 17;102(22):1731-40. doi: 10.1093/jnci/djq389. Epub 2010 Oct 5. J Natl Cancer Inst. 2010. PMID: 20923998 Free article.
Diagnosis of Constitutional Mismatch Repair-Deficiency Syndrome Based on Microsatellite Instability and Lymphocyte Tolerance to Methylating Agents.
Bodo S, Colas C, Buhard O, Collura A, Tinat J, Lavoine N, Guilloux A, Chalastanis A, Lafitte P, Coulet F, Buisine MP, Ilencikova D, Ruiz-Ponte C, Kinzel M, Grandjouan S, Brems H, Lejeune S, Blanché H, Wang Q, Caron O, Cabaret O, Svrcek M, Vidaud D, Parfait B, Verloes A, Knappe UJ, Soubrier F, Mortemousque I, Leis A, Auclair-Perrossier J, Frébourg T, Fléjou JF, Entz-Werle N, Leclerc J, Malka D, Cohen-Haguenauer O, Goldberg Y, Gerdes AM, Fedhila F, Mathieu-Dramard M, Hamelin R, Wafaa B, Gauthier-Villars M, Bourdeaut F, Sheridan E, Vasen H, Brugières L, Wimmer K, Muleris M, Duval A; European Consortium “Care for CMMRD”. Bodo S, et al. Among authors: chalastanis a. Gastroenterology. 2015 Oct;149(4):1017-29.e3. doi: 10.1053/j.gastro.2015.06.013. Epub 2015 Jun 25. Gastroenterology. 2015. PMID: 26116798 Free article.
[Clinical and molecular consequences of microsatellite instability in human cancers].
Hamelin R, Chalastanis A, Colas C, El Bchiri J, Mercier D, Schreurs AS, Simon V, Svrcek M, Zaanan A, Borie C, Buhard O, Capel E, Zouali H, Praz F, Muleris M, Fléjou JF, Duval A. Hamelin R, et al. Among authors: chalastanis a. Bull Cancer. 2008 Jan;95(1):121-32. doi: 10.1684/bdc.2008.0571. Bull Cancer. 2008. PMID: 18230578 Review. French.
The mechanisms underlying MMR deficiency in immunodeficiency-related non-Hodgkin lymphomas are different from those in other sporadic microsatellite instable neoplasms.
Borie C, Colas C, Dartigues P, Lazure T, Rince P, Buhard O, Folliot P, Chalastanis A, Muleris M, Hamelin R, Mercier D, Oliveira C, Seruca R, Chadburn A, Leblond V, Barete S, Gaïdano G, Martin A, Gaulard P, Fléjou JF, Raphael M, Duval A. Borie C, et al. Among authors: chalastanis a. Int J Cancer. 2009 Nov 15;125(10):2360-6. doi: 10.1002/ijc.24681. Int J Cancer. 2009. PMID: 19551857
Cancer-Associated IDH1 Promotes Growth and Resistance to Targeted Therapies in the Absence of Mutation.
Calvert AE, Chalastanis A, Wu Y, Hurley LA, Kouri FM, Bi Y, Kachman M, May JL, Bartom E, Hua Y, Mishra RK, Schiltz GE, Dubrovskyi O, Mazar AP, Peter ME, Zheng H, James CD, Burant CF, Chandel NS, Davuluri RV, Horbinski C, Stegh AH. Calvert AE, et al. Among authors: chalastanis a. Cell Rep. 2017 May 30;19(9):1858-1873. doi: 10.1016/j.celrep.2017.05.014. Cell Rep. 2017. PMID: 28564604 Free PMC article.
Dual bioluminescence and near-infrared fluorescence monitoring to evaluate spherical nucleic acid nanoconjugate activity in vivo.
Sita TL, Kouri FM, Hurley LA, Merkel TJ, Chalastanis A, May JL, Ghelfi ST, Cole LE, Cayton TC, Barnaby SN, Sprangers AJ, Savalia N, James CD, Lee A, Mirkin CA, Stegh AH. Sita TL, et al. Among authors: chalastanis a. Proc Natl Acad Sci U S A. 2017 Apr 18;114(16):4129-4134. doi: 10.1073/pnas.1702736114. Epub 2017 Apr 3. Proc Natl Acad Sci U S A. 2017. PMID: 28373576 Free PMC article.
Bcl2L13 is a ceramide synthase inhibitor in glioblastoma.
Jensen SA, Calvert AE, Volpert G, Kouri FM, Hurley LA, Luciano JP, Wu Y, Chalastanis A, Futerman AH, Stegh AH. Jensen SA, et al. Among authors: chalastanis a. Proc Natl Acad Sci U S A. 2014 Apr 15;111(15):5682-7. doi: 10.1073/pnas.1316700111. Epub 2014 Mar 31. Proc Natl Acad Sci U S A. 2014. PMID: 24706805 Free PMC article.